- Home
- TOL vs SNN Comparison
TOL vs SNN Comparison
Compare TOL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOL | SNN |
|---|---|---|
| Founded | 1967 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Homebuilding | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | TOL | SNN |
|---|---|---|
| Price | $140.54 | $32.29 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $150.73 | $32.83 |
| AVG Volume (30 Days) | ★ 1.3M | 497.0K |
| Earning Date | 12-08-2025 | 03-02-2026 |
| Dividend Yield | 0.72% | ★ 2.24% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 13.49 | 0.56 |
| Revenue | ★ $10,966,723,000.00 | $5,944,000,000.00 |
| Revenue This Year | N/A | $7.78 |
| Revenue Next Year | $3.78 | $5.13 |
| P/E Ratio | ★ $10.32 | $28.10 |
| Revenue Growth | 1.11 | ★ 5.35 |
| 52 Week Low | $86.67 | $23.69 |
| 52 Week High | $149.79 | $38.79 |
Technical Indicators
Market Signals| Indicator | TOL | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 39.19 |
| Support Level | $138.36 | $32.97 |
| Resistance Level | $141.58 | $33.60 |
| Average True Range (ATR) | 4.10 | 0.42 |
| MACD | 0.28 | 0.06 |
| Stochastic Oscillator | 72.71 | 10.81 |
Price Performance
Historical ComparisonAbout TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.